2-甲基咪唑
2-Methyl-1H-imidazole;2-METHYLGLYOXALINE;2-METHYLIMIDAZOLE;2MI;RESICURE(TM) 46;1H-Imidazole,2-methyl-;2-methyl-1h-imidazol;2-methyl-imidazol;2MZ;Glyoxalethyline;Imidazole, 2-methyl-;p-Oxal-methyline;Flucythrinate PESTANAL;2-METHYLIMIDAZOLE pure;Curezol 2MZ;Denka CN 25;2-Methylimidazole (Ondansetron Impurity F);2-Methylimidazole Standard;2-methyl-imidazole;2MZ-H;2MZ-PW;Actiron 2MI;Epicure MI 2;Epikure MI 2;Ondansetron impurity F (PhEur);Ondansetron impurity F;2-甲基咪唑;1H-Imidazole, 2-methyl-;2-methyl imidazole;LXBGSDVWAMZHDD-UHFFFAOYSA-N;T0049Z45LZ;DSSTox_CID_2107;DSSTox_RID_76489;DSSTox_GSID_22107;methylimidazol;Methyl imidazol;methyl imidazole;methyl-imidazole;2methylimidazole;2-methylimidazol;2-metylimidazole;2-Methylimdazole;NSC 21394;693-98-1;HMS3039F06;M0345;SMR000568464;Ondansetron impurity F, European Pharmacopoeia (EP) Reference Standard;2-Methylglyoxaline;DTXSID4022107;2-Methyl glyoxaline;Tox21_201316;C19261;NSC 21394-d5;WLN: T5M CNJ B1;PD063450;CAS-693-98-1;2-Methylimidazole (Ondansetron Impurity F), Pharmaceutical Secondary Standard; Certified Reference Material;IMICURE-AMI 2;FT-0671849;CS-W019983;MFCD00005190;EINECS 211-765-7;ONDANSETRON HYDROCHLORIDE IMPURITY, 2-METHYLIMIDAZOLE- [USP IMPURITY];Tox21_302808;NCGC00258868-01;EC 211-765-7;AKOS000118836;NCGC00256531-01;F2190-0640;A833348;AM20100647;UNII-T0049Z45LZ;STR02220;AI3-50033;2-Methylimidazole, >=95.0% (HPLC), pharmaceutical impurity standard;FT-0613056;EPIKURE-MI 2;NCGC00091456-02;HSDB 7756;ONDANSETRON HYDROCHLORIDE DIHYDRATE IMPURITY F [EP IMPURITY];METHYLIMIDAZOLE, 2-;DTXCID202107;PB43299;2-METHYLIMIDAZOLE [HSDB];2-Methylimidazole, 99%;W-104630;NS00010845;Q21099566;2-Methyl-1H-imidazole; 1H-2-Methylimidazole; 2-Methylimidazole; 2MI; 2MZ; 2MZ-H;Z104494990;CHEMBL293391;CCRIS 2459;EPICURE-MI 2;2-METHYLIMIDAZOLE [IARC];NSC21394;CUREZOL-2MZ-P;MLS001065618;methylimidazole;EN300-21278;InChI=1/C4H6N2/c1-4-5-2-3-6-4/h2-3H,1H3,(H,5,6;NCGC00091456-01;Tox21_111136;BDBM50295560;NSC-21394;D77862;A836474;Ondansetron(Imp. F)